Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Julie Makani: Advances and Challenges in Sickle Cell and Beta Thalassemia Treatment
Sep 27, 2026, 13:19

Julie Makani: Advances and Challenges in Sickle Cell and Beta Thalassemia Treatment

Julie Makani, Science Advisor at East Central and Southern Africa Health Community, shared POST, UK Parliament‘s post on LinkedIn:

“POST, UK Parliament supports Sickle Cell and Thalassaemia.

September is Sickle Cell Awareness Month.

POST, UK Parliament:

The Parliamentary Office of Science and Technology (POST) is an impartial research and knowledge exchange service based in the UK Parliament.”

POST, UK Parliament shared a post on LinkedIn about a recent article by Natasha Mutebi, published in POST, adding:

“September is Sickle Cell Awareness Month.

Sickle cell disorder and beta thalassemia are inherited blood conditions that can reduce life expectancy and quality of life.

They disproportionately affect people of African, Caribbean, South Asian, Mediterranean and Middle Eastern backgrounds.

Our 2025 peer-reviewed POSTnote looks at the treatment options for these conditions, including new approaches such as personalised gene therapy, and the challenges around access, awareness and providing care.”

Title: Sickle cell and beta thalassemia: what are the treatment options and challenges?

Authors: Natasha Mutebi

Julie Makani: Advances and Challenges in Sickle Cell and Beta Thalassemia Treatment

Stay updated on all scientific advances with Hemostasis Today.